As shown in Figure S4C, with the increase in risk score, the survival rate of glioma patients significantly decreased, consistent with the results that HIC2 and IDH1 mutations were protective factors, while age and grade were risk factors in glioma. This evidence concerns the gene HIC2 and central nervous system cancer.